Trailing-twelve-month (TTM) revenue is $1.06 Million with a year-over-year growth of (26.88%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $370,593 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $399,133 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-13 |
| Q1 FY2026Period ended 2026-03-31 | $273,658 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $13,693 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $1,057,077 |
Current P/S: $2,101,315 market capitalization ÷ $1,057,077 TTM revenue = 1.99x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:43:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $13693.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:45:39.052Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Energized Mineral Concentrate | $43,487 | $59,024 |
| Health and Wellness Services | $207,546 | $169,299 |
| Ionized Cal Mag | $388 | N/A |
| Product | N/A | $1M |
| Product Health Therapies | $913,297 | $912,239 |
$1.06M
$1.06 Million
(26.88%)
vs. $1.45M a year ago (TTM)
(16.05%)
5 Year compound annual growth rate
1 Year
(26.88%)
3 Year
(15.23%)
5 Year
(16.05%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.52M | +$201,515 | +15.23% |
| 2024 | $1.32M | ($108,341) | (7.57%) |
| 2023 | $1.43M | ($425,476) | (22.92%) |
| 2022 | $1.86M | +$839,602 | +82.56% |
| 2021 | $1.02M | ($2.44M) | (70.55%) |
| 2020 |
TTM Growth
(26.88%)
3-Year CAGR
(15.23%)
5-Year CAGR
(16.05%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 28 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:45:39.052Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $3.45M |
| +$2.59M |
| +302.06% |
| 2019 | $858,724 | ($687,333) | (44.46%) |
| 2018 | $1.55M | +$1.06M | +217.46% |
